Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorouracil, Phenylbutyrate, Indomethacin, and Interferon-Gamma in Advanced Colorectal Cancer
NCT00002796Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- May 1997
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in colorectal cancer (CRC), sponsored by National Cancer Institute. Primary endpoints: Dose-Limiting Toxicity at 1 week and Efficacy at 7 years. Started May 1997; status: terminated.
02
Drugs
fluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00002796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002796.